IDH1 and diffuse midline glioma: The molecular biomarkers for classification of adult diffuse gliomas include mutations in IDH1/2 (IDH) and H3F3A (K27M mutation in diffuse midline gliomas) genes, as well as the 1p/19q codeletion (in oligodendrogliomas).